{"id":433278,"title":"Access to biosimilars and communicating with patients: Handbook for health care professionals on biosimilar biologic drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:54:03.834000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs/handbook-healthcare-professionals/access-communicating-patients.html","snippet":"Handbook for health care professionals on biosimilar biologic drugs: Access to biosimilars and communicating with patients Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Health…","rawSnapshotUrl":"/api/snapshots/raw/433278","browseUrl":"https://replay.healtharchive.ca/job-6/20260102095403/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs/handbook-healthcare-professionals/access-communicating-patients.html#ha_snapshot=433278","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}